NeoGenomics Inc (NEO)
13.43
-0.10
(-0.74%)
USD |
NASDAQ |
Apr 22, 16:00
13.60
+0.17
(+1.27%)
Pre-Market: 08:30
NeoGenomics Shareholders Equity (Quarterly): 941.54M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 941.54M |
September 30, 2023 | 947.43M |
June 30, 2023 | 956.19M |
March 31, 2023 | 974.46M |
December 31, 2022 | 998.02M |
September 30, 2022 | 1.013B |
June 30, 2022 | 1.044B |
March 31, 2022 | 1.075B |
December 31, 2021 | 1.108B |
September 30, 2021 | 1.137B |
June 30, 2021 | 1.148B |
March 31, 2021 | 843.71M |
December 31, 2020 | 694.29M |
September 30, 2020 | 666.36M |
June 30, 2020 | 654.23M |
March 31, 2020 | 505.04M |
December 31, 2019 | 507.41M |
September 30, 2019 | 497.01M |
June 30, 2019 | 489.73M |
March 31, 2019 | 323.85M |
December 31, 2018 | 320.44M |
September 30, 2018 | 303.56M |
June 30, 2018 | 164.21M |
March 31, 2018 | 208.02M |
December 31, 2017 | 204.58M |
Date | Value |
---|---|
September 30, 2017 | 199.66M |
June 30, 2017 | 196.57M |
March 31, 2017 | 194.02M |
December 31, 2016 | 186.60M |
September 30, 2016 | 246.09M |
June 30, 2016 | 243.37M |
March 31, 2016 | 240.17M |
December 31, 2015 | 238.11M |
September 30, 2015 | 61.85M |
June 30, 2015 | 60.87M |
March 31, 2015 | 60.16M |
December 31, 2014 | 60.40M |
September 30, 2014 | 59.06M |
June 30, 2014 | 23.13M |
March 31, 2014 | 22.50M |
December 31, 2013 | 21.71M |
September 30, 2013 | 20.33M |
June 30, 2013 | 19.44M |
March 31, 2013 | 18.83M |
December 31, 2012 | 9.216M |
September 30, 2012 | 9.222M |
June 30, 2012 | 9.719M |
March 31, 2012 | 8.67M |
December 31, 2011 | 5.897M |
September 30, 2011 | 5.36M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
489.73M
Minimum
Jun 2019
1.148B
Maximum
Jun 2021
852.68M
Average
947.43M
Median
Sep 2023
Shareholders Equity (Quarterly) Benchmarks
Teladoc Health Inc | 2.326B |
Abbott Laboratories | 38.60B |
Halozyme Therapeutics Inc | 83.81M |
Verastem Inc | 57.37M |
Ocugen Inc | 40.56M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 1.681B |
Total Liabilities (Quarterly) | 739.69M |
Debt to Equity Ratio | 0.5716 |
Current Ratio | 6.197 |
Net Debt Paydown Yield | -0.03% |